๐๏ธ Verified NIH Record โข Updated 2026-07-23
A Clinical Trial of Telehealth Treatment for Opioid Use Disorders (NCT07362082)
๐ก Not Yet Recruiting Observational / Diagnostic โ๏ธ Medical Device Protocol Sponsor: Yale University
๐ฉบ Plain-English Summary (8th-Grade Level)
This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (5 items).
Location: Yale University โ New Haven, Connecticut
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
- Pregnancy
- Known current suicide risk based on participant self-report
- On parole or incarcerated at time of enrollment based on participant self-report
๐ Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
๐ All Participating Trial Locations (1 Sites)
- Yale University โ New Haven, Connecticut
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.